Cloning of a single-chain variable fragment (scFv) switching active plasminogen activator inhibitor-1 to substrate

Gene

Volumn 189, Issue 1, 1997, Pages 83-88

  Debrock, Sophie ^a   Sironi, Luigi ^a   Declerck, Paul J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Monoclonal antibody; PAI 1; Serpin; Single chain variable fragment

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR;

ANTIGEN BINDING; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SUBSTRATE; EXPRESSION VECTOR; MOLECULAR CLONING; NONHUMAN; PHAGEMID; PRIORITY JOURNAL; PROTEIN CONFORMATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CLONING, MOLECULAR; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY;

EID: 0030896006     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(96)00838-4     Document Type: Article

References (27)

1. Abrahamsson, T., Björquist, P., Deinum, J., Ehnebom, J., Hulander, M., Legnehed, A., Matsson, C., Nerme, V., Westin-Eriksson, A. and Åkerblom, B. (1994) An antibody fragment against PAI-I inhibits PAI-I activity and stimulates fibrinolysis in vitro and in vivo. Fibrinolysis 8 (Suppl. 2), 55-56.
2. Abrahamsson, T., Nerme, V., Strömqvist, M., Åkerblom, B., Legnehed, A., Pettersson, K. and Westin-Eriksson, A. (1996) Antithrombotic effect of a PAI-I inhibitor in rats given endotoxin. Thromb. Haemost. 75, 118-126.
3. Andreasen, P.A., Riccio, A., Welinder, K.G., Douglas, R., Sartorio, R., Nielsen, L.S., Oppenheimer, C., Blasi, F. and Danø, K. (1986) Plasminogen activator inhibitor type 1: reactive center and aminoterminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett. 209, 213-218.
4. Audenaert, A.-M., Knockaert, I., Collen, D. and Declerck, P.J. (1994) Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop. J. Biol. Chem. 269, 19559-19564.
5. Biemond, B.J., Levi, M., Coronel, R., Janse, M.J., Ten Cate, J.W. and Pannekoek, H. (1995) Thrombolysis and reocclusion in experimental jugular vein and artery thrombosis: effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody. Circulation 91, 1175-1181.
6. Debrock, S. and Declerck, P.J. (1995) Characterization of common neoantigenic epitopes generated in plasminogen activator inhibitor-1 after cleavage of the reactive center loop or after complex formation with various serine proteinases. FEBS Lett. 376, 243-246.
7. Debrock, S. and Declerck, P.J. (1997) Neutralization of plasminogen activator inhibitor-1 inhibitory properties: Identification of two different mechanisms. Biochim. Biophys. Acta 1337, 255-266.
8. Declerck, P.J., De Mol, M., Vaughan, D.E. and Collen, D. (1992) Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a non-inhibitory substrate for tissue-type plasminogen activator. J. Biol. Chem. 267, 11693-11696.
9. Eitzman, D.T., Fay, W.P., Lawrence, D.A., Francis-Chmura, A.M., Shore, J.D., Olson, S.T. and Ginsburg, D. (1995) Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro. J. Clin. Invest. 95, 2416-2420.
10. Ey, P.L., Prowse, S.J. and Jenkins, C.R. (1978) Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins form mouse serum using protein A-Sepharose. Immunochemistry 15, 429-436.
11. Ginsburg, D., Zeheb, R., Yang, A.Y., Rafferty, U.M., Andreasen, P.A., Nielsen, L., Danø, K., Lebo, R.V. and Gelehrter, T.D. (1986) cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J. Clin. Invest. 78, 1673-1680.
12. Hoogenboom, H.R., Griffiths, A.D., Johnson, K.S., Chiswell, D.J., Hudson, P. and Winter, G. (1991) Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19, 4133-4137.
13. Hoogenboom, H.R., Marks, J.D., Griffiths, A.D. and Winter, G. (1992) Building antibodies from their genes. Immunol. Rev. 130, 40-67.
14. Kabat, E.A., Wu, T.T., Reid-Miller, M., Perry, H.M. and Gottesman, K.S. (1987) Sequences of Proteins of Immunological Interest, 4th Edn. Public Health Service N.I.H., U.S. Department of Health and Human Services, Washington, DC.
15. Laskowski Jr., M. and Kato, I. (1980) Protein inhibitors of proteinases. Annu. Rev. Biochem. 49, 593-626.
16. Levi, M., Biemond, B.J., Van Zonneveld, A-J., Ten Cate, J.W. and Pannekoek, H. (1992) Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 85, 305-312.
17. McCafferty, J., Griffiths, A.D., Winter, G. and Chiswell, D.J. (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552-554.
18. Munch, M., Heegaard, C.W. and Andreasen, P.A. (1993) Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor. Biochim. Biophys. Acta 1202, 29-37.
19. Ny, T., Sawdey, M., Lawrence, D., Millan, J.L. and Loskutoff, D.J. (1986) Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc. Natl. Acad. Sci USA 83, 6776-6780.
20. Pannekoek, H., Veerman, H., Lambers, H., Diergaarde, P., Verweij, C.L., Van Zonneveld, A.-J. and Van Mourik, J.A. (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the serpin gene family. EMBO J. 5, 2539-2544.
21. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci USA 74, 5463-5467.
23. Skerra, A. Pfitzinger, I. and Plückthun, A. (1991) The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and a generally applicable purification technique. Biotechnology 9, 273-278.
24. Urano, T., Strandberg, L., Johansson, L.B. and Ny, T. (1992) A substrate-like form of plasminogen activator inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate. Eur. J. Biochem. 209, 985-992.
25. Verheijen, J.H., Chang, G.T.G. and Kluft, C. (1984) Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb. Haemost. 51, 392-395.
26. Winter, G., Griffiths, A.D., Hawkins, R.E. and Hoogenboom, H.R. (1994) Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433-455.
27. Winter, G. and Milstein, C. (1991) Man-made antibodies. Nature 349, 293-299.